Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesOther Gross PP&E Adjustments
Ratios

RedHill Biopharma (RDHL) Shares Issued (2016 - 2023)

Historic Shares Issued for RedHill Biopharma (RDHL) over the last 7 years, with Q4 2022 value amounting to $7.6 million.

  • RedHill Biopharma's Shares Issued fell 6173.64% to $7.6 million in Q4 2022 from the same period last year, while for Dec 2022 it was $23.8 million, marking a year-over-year decrease of 6968.78%. This contributed to the annual value of $8.3 million for FY2024, which is 4080.52% down from last year.
  • Latest data reveals that RedHill Biopharma reported Shares Issued of $7.6 million as of Q4 2022, which was down 6173.64% from $15.5 million recorded in Q2 2022.
  • Over the past 5 years, RedHill Biopharma's Shares Issued peaked at $57.9 million during Q1 2021, and registered a low of $273000.0 during Q2 2021.
  • Moreover, its 4-year median value for Shares Issued was $8.4 million (2020), whereas its average is $13.0 million.
  • Data for RedHill Biopharma's Shares Issued shows a peak YoY increase of 558058.61% (in 2022) and a maximum YoY decrease of 9876.94% (in 2022) over the last 5 years.
  • RedHill Biopharma's Shares Issued (Quarter) stood at $18.3 million in 2018, then crashed by 54.4% to $8.4 million in 2020, then skyrocketed by 136.92% to $19.8 million in 2021, then tumbled by 61.74% to $7.6 million in 2022.
  • Its Shares Issued stands at $7.6 million for Q4 2022, versus $15.5 million for Q2 2022 and $713000.0 for Q1 2022.